BackVenus Acquisition - Tradeable Rights - April 2021 Overview

Venus Acquisition - Tradeable Rights - April 2021 Total Liabilities

Venus Acquisition - Tradeable Rights - April 2021's total liabilities is $19M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$19.38M
↑ 92.94% YoYΔ $9.34M vs prior year quarter

Peer trimmed avg / median

Loading

Venus Acquisition - Tradeable Rights - April 2021 Total Liabilities History

Loading

Venus Acquisition - Tradeable Rights - April 2021 vs. peers: Total Liabilities Comparison

Loading

Venus Acquisition - Tradeable Rights - April 2021 Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Venus Acquisition - Tradeable Rights - April 2021 (VENAR) FAQ

As of the most recent data (June 2026), VENAR shows a total liabilities of $19M. That compares with $10M in the prior-year period — up 92.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VENAR's total liabilities is now $19M (was $10M) — a 92.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Venus Acquisition - Tradeable Rights - April 2021 is outperforming or lagging.

Tracking VENAR's total liabilities over time shows whether Venus Acquisition - Tradeable Rights - April 2021 is scaling, shrinking, or reshaping that part of the business. The current reading is $19M That compares with $10M in the prior-year period — up 92.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Venus Acquisition - Tradeable Rights - April 2021's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $19M) with ownership activity and broader fundamentals.